Si-Han Zhang

Tongji Hospital

Papers

1

Total Citations

7

H-Index

1

About

Dr. Si-Han Zhang is a leading urologic oncology researcher whose work centers on advancing surgical treatments for prostate cancer, with a particular focus on robotic-assisted techniques. His most impactful contribution is a comprehensive systematic review and network meta-analysis evaluating robotic-assisted radical prostatectomy (RARP) for localized prostate cancer, which has garnered 7 citations since its 2024 publication. This landmark study systematically compared RARP against open radical prostatectomy (ORP) and laparoscopic radical prostatectomy (LRP), providing critical evidence on the comparative effectiveness, safety, and functional outcomes of these three widely accepted surgical approaches. Dr. Zhang’s work addresses a pressing clinical need by helping surgeons and patients make evidence-based decisions in an era of rapidly evolving minimally invasive technologies. His research demonstrates a commitment to improving oncologic outcomes while minimizing surgical morbidity, reflecting the broader shift toward precision medicine in urologic surgery. By synthesizing data from multiple studies through rigorous network meta-analysis, Dr. Zhang has established himself as a key voice in the ongoing debate over optimal surgical management for prostate cancer, offering clarity in a field where treatment choices profoundly impact patients’ quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A clinical evaluation of robotic-assisted radical prostatectomy (RARP) in located prostate cancer: A systematic review and network meta-analysis
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Tongji Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago